NOVARTIS AG

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange NOVARTIS AG stocks are traded under the ticker NOT.

NOVARTIS AG is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.

NOT earnings for the last quarter are 1.39 EUR per share, whereas the estimation was 1.50 EUR resulting in a −7.31% surprise. The estimated earnings for the next quarter are 1.55 EUR per share. See more details about NOVARTIS AG earnings.

NOVARTIS AG revenue for the last quarter amounts to ‪10.35 B‬ EUR despite the estimated figure of ‪10.77 B‬ EUR. In the next quarter revenue is expected to reach ‪10.60 B‬ EUR.

Yes, you can track NOVARTIS AG financials in yearly and quarterly reports right on TradingView.

Yes, NOT dividends are paid annually. The last dividend per share was 3.43 EUR. As of today, Dividend Yield (TTM)% is 3.67%. Tracking NOVARTIS AG dividends might help you take more informed decisions.

NOVARTIS AG dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG stock right from TradingView charts — choose your broker and connect to your account.

As of Apr 26, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS AG on this list?

We've gathered analysts' opinions on NOVARTIS AG future price: according to them, NOT price has a max estimate of 122.17 EUR and a min estimate of 75.94 EUR. Read a more detailed NOVARTIS AG forecast: see what analysts think of NOVARTIS AG and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG EBITDA is ‪19.27 B‬ EUR, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG financial statements.